Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check3 days agoChange DetectedMinor site revision updating from v3.4.0 to v3.4.1 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedThe update adds a glossary toggle and updates UI/metadata labels, including capitalization changes for QC criteria text and the No FEAR Act Data label, and upgrades the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page header, indicating a minor maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Study Details page reorganizes location data by removing the state-specific 'Florida Locations', 'Michigan Locations', and 'Texas Locations' subsections and introducing a general 'Locations' section. This update (revision v3.3.3) changes how locations are presented to users.SummaryDifference0.3%

- Check68 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. This appears to be a minor update with no visible changes to page content or layout.SummaryDifference0.0%

- Check75 days agoChange DetectedA new note in the Publications section explains that items are automatically filled from PubMed and may not be about the study. The page now shows Revision: v3.3.1 and includes the advisory text: 'To avoid being alerted by small changes, set an alert condition by clicking below.'SummaryDifference0.1%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.